CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 84 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2018. The put-call ratio across all filers is 3.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $727,000 | +19.0% | 104,543 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $611,000 | -56.6% | 104,543 | -43.9% | 0.00% | 0.0% |
| Q3 2018 | $1,408,000 | +196.4% | 186,358 | +98.0% | 0.00% | 0.0% |
| Q2 2018 | $475,000 | -17.2% | 94,117 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $574,000 | -4.2% | 94,117 | +11.6% | 0.00% | 0.0% |
| Q4 2017 | $599,000 | -0.7% | 84,326 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $603,000 | +19.9% | 84,326 | +5.7% | 0.00% | 0.0% |
| Q2 2017 | $503,000 | – | 79,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |